Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same.

Olry, Alexandre; Meunier, Lucy; Délire, Bénédicte; Larrey, Dominique; Horsmans, Yves; Le Louët, Hervé

Olry, Alexandre; Meunier, Lucy; Délire, Bénédicte; Larrey, Dominique; Horsmans, Yves; Le Louët, Hervé.

Affiliation

Olry A; Pharmacovigilance Department, Henri Mondor University Hospital (APHP), 51 Avenue du Maréchal de Lattre de Tassigny, Créteil, 94010, Paris, France. alexandre.olry@aphp.fr.
Meunier L; Liver Unit, Saint-Eloi Hospital, INSERM 1183, Montpellier School of Medicine, Montpellier, France.
Délire B; Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCL), Brussels, Belgium.
Larrey D; Liver Unit, Saint-Eloi Hospital, INSERM 1183, Montpellier School of Medicine, Montpellier, France.
Horsmans Y; Department of Hepatogastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (UCL), Brussels, Belgium.
Le Louët H; CIOMS, Head of Vigilance Department, Henri Mondor University Hospital (APHP), Paris, France.

Drug Saf ; 43(7): 615-617, 2020 07.

Article in En | MEDLINE | ID: mdl-32514859

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Pneumonia, Viral / Coronavirus Infections / Chemical and Drug Induced Liver Injury / Pandemics / Liver Function Tests Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Drug Saf Journal subject: TERAPIA POR MEDICAMENTOS / TOXICOLOGIA Year: 2020 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google